How should multiple small, firm, non‑tender subcutaneous nodules be evaluated and managed?

Evaluation and Management of Multiple Small, Firm, Non-Tender Subcutaneous Nodules

For multiple small, firm, non-tender subcutaneous nodules, obtain an ultrasound within 2 weeks to characterize the lesions, followed by core needle biopsy for any suspicious features (size >2 cm, deep location, or concerning imaging characteristics) to exclude soft tissue sarcoma.

Initial Imaging Approach

The most recent UK guidelines for soft tissue sarcomas 1 establish that any unexplained lump should be evaluated with direct access ultrasound within 2 weeks. This is your first-line imaging modality.

Ultrasound Characteristics to Assess:

• Size: Lesions <2 cm that appear benign on imaging can be managed with planned excision biopsy 1
• Depth: Superficial subcutaneous lesions versus deep involvement
• Echogenicity pattern: Lipomas typically show hyperechoic patterns 2
• Vascularity: Use color Doppler to assess intralesional blood flow—benign lesions typically lack internal vascularity 3

Diagnostic Algorithm Based on Imaging

For Small Lesions (<2 cm, Indeterminate on Imaging):

• Planned excision biopsy is the most practical approach 1
• These usually prove benign, but if sarcoma is identified, perform wide excision of the surgical bed subsequently

For Larger or Suspicious Lesions (≥2 cm or Concerning Features):

• Percutaneous core needle biopsy is the standard diagnostic approach 1
• Take multiple cores to maximize diagnostic yield
• Use image guidance by radiology for optimal sampling
• Plan biopsy tract so it can be excised during definitive surgery if needed

For Deep Lesions:

• Advance to MRI or CT to exclude involvement of underlying structures and differentiate from liposarcoma 2

Common Benign Diagnoses to Consider

The differential diagnosis includes:

• Lipomas (most common)—occur on trunk and proximal extremities, up to 50% contain atypical fat cells 2
• Ganglion cysts—confirm with ultrasound if not clinically apparent 2
• Epidermal inclusion cysts—typically asymptomatic unless infected 2
• Subcutaneous granuloma annulare—painless nodules of extremities or scalp, particularly in children (mean age 4.3 years) 4

Critical Pitfalls to Avoid

1. Do not use fine needle aspiration as primary diagnostic modality for suspected sarcomas—it is inadequate for diagnosis 1

2. Do not delay biopsy due to concerns about tract seeding—the risk is very small and should not undermine obtaining pre-treatment histological diagnosis 1

3. Do not perform incision biopsy except in exceptional circumstances after discussion with sarcoma specialist unit 1

4. Ensure specialist pathology review if initial biopsy performed outside sarcoma centers—discordance rates range from 8-11% for major discrepancies and 16-35% for minor discrepancies 1

When Malignancy is Suspected

If imaging suggests possible sarcoma:

• Obtain additional biopsy cores for fresh tissue snap freezing and whole genome sequencing 1
• Perform staging CT chest/abdomen/pelvis
• Consider PET-CT in specific scenarios (before radical surgery, or for certain subtypes) 1

Special Considerations

In patients receiving depot somatostatin analogs: Nodules may represent injection site reactions rather than metastases—high-resolution ultrasound shows characteristic hyperechoic peripheral rim in long-term injections (>3 months), with no intralesional vascularity on Doppler 3

Post-immunization nodules: Rare adverse events, frequently associated with aluminum-containing vaccines—these are benign and do not contraindicate future immunizations 5